adezunap (AP707) / CannaXan, Apurano Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
adezunap (AP707) / CannaXan, Apurano Pharma
NCT06072573: Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy

Recruiting
3
558
Europe
Adezunap (AP707), Placebo
Apurano Pharmaceuticals GmbH
Pain, Pain Syndrome, Pain, Chronic, Chronic Pain, Chronic Pain Syndrome, Diabetes, Diabetic Neuropathies, Diabetic Polyneuropathy, Peripheral Neuralgia, Peripheral Neuropathy, Peripheral Neuropathy With Type 2 Diabetis
09/24
12/24
NCT06072560: Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

Recruiting
3
558
Europe
Adezunap (AP707), Placebo
Apurano Pharmaceuticals GmbH
Pain, Pain Syndrome, Pain, Chronic, Chronic Pain, Chronic Pain Syndrome, Back Pain, Lower Back Pain, Lower Back Pain Chronic
09/24
12/24
NCT06072001: Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

Recruiting
3
558
Europe
Adezunap (AP707), Placebo
Apurano Pharmaceuticals GmbH
Pain, Pain Syndrome, Pain, Chronic, Chronic Pain, Chronic Pain Syndrome, Neuropathic Pain, Central Neuropathic Pain, Paraplegia, Multiple Sclerosis, Stroke, Phantom Limb Syndrome With Pain, Phantom Pain, Traumatic Brain Injury
09/24
12/24
NCT06071988: Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

Recruiting
3
558
Europe
Adezunap (AP707), Placebo
Apurano Pharmaceuticals GmbH
Pain, Pain Syndrome, Pain, Chronic, Chronic Pain, Chronic Pain Syndrome, Neuropathic Pain, Peripheral Neuropathy, Peripheral Neuralgia, Peripheral Nerve Injury, Post Operative Pain, Post-Traumatic Neuralgia, Plexopathy
09/24
12/24
NCT06071975: Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy

Recruiting
3
558
Europe
Adezunap (AP707), Placebo
Apurano Pharmaceuticals GmbH
Pain, Pain Syndrome, Pain, Chronic, Chronic Pain, Chronic Pain Syndrome, Diabetes, Diabetic Neuropathies, Diabetic Polyneuropathy, Peripheral Neuralgia, Peripheral Neuropathy, Peripheral Neuropathy With Type 2 Diabetis
09/24
12/24
NCT06071962: Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

Recruiting
3
558
Europe
Adezunap (AP707), Placebo
Apurano Pharmaceuticals GmbH
Pain, Pain Syndrome, Pain, Chronic, Chronic Pain, Chronic Pain Syndrome, Back Pain, Lower Back Pain, Lower Back Pain Chronic
09/24
12/24
NCT06071949: Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

Recruiting
3
558
Europe
Adezunap, Placebo
Apurano Pharmaceuticals GmbH
Pain, Pain Syndrome, Pain, Chronic, Chronic Pain, Chronic Pain Syndrome, Neuropathic Pain, Central Neuropathic Pain, Paraplegia, Multiple Sclerosis, Stroke, Phantom Limb Syndrome With Pain, Phantom Pain, Traumatic Brain Injury
09/24
12/24
NCT06071936: Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

Recruiting
3
558
Europe
Adezunap (AP707), Placebo
Apurano Pharmaceuticals GmbH
Pain, Pain Syndrome, Pain, Chronic, Chronic Pain, Chronic Pain Syndrome, Neuropathic Pain, Peripheral Neuropathy, Peripheral Neuralgia, Peripheral Nerve Injury, Post Operative Pain, Post-Traumatic Neuralgia, Plexopathy
09/24
12/24

Download Options